中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
6期
93-95
,共3页
易文彪%王万明%陈庆泉%程俊华
易文彪%王萬明%陳慶泉%程俊華
역문표%왕만명%진경천%정준화
Zero-P%颈椎%融合
Zero-P%頸椎%融閤
Zero-P%경추%융합
Zero-P%Cervical%Fusion
目的:研究Zero-P椎间融合器在颈椎前路减压椎体间融合(ACDF)术后的早期临床疗效。方法:选取颈椎疾病患者31例,均行ACDF术,共置入Zero-P椎间融合器31枚,融合节段均为单节段。术后定期摄X线片检查,采用日本骨科学会(JOA)评分,神经功能改善率(RIS)评价患者术前、术后颈脊髓神经功能。结果:31例患者均获12个月以上随访,平均14.70个月,手术时间(72±10)min,术中出血量(60±12)mL;1例患者术后24 h内出现咽部疼痛,经对症治疗,术后7 d内症状消失;术后3个月X线片提示颈椎椎间隙骨性融合,术前JOA评分(8.65±1.85)分,术后末次随访时为(16.09±0.91)分,差异有统计学意义(P<0.05);术后6个月神经功能改善率为(89.60±9.45)%,与术后12个月的(90.30±8.94)%比较,差异无统计学意义(P>0.05);术后椎间高度、生理弧度恢复满意。结论:Zero-P椎间融合器应用于颈前路减压植骨融合治疗颈椎疾病的早期随访疗效满意。
目的:研究Zero-P椎間融閤器在頸椎前路減壓椎體間融閤(ACDF)術後的早期臨床療效。方法:選取頸椎疾病患者31例,均行ACDF術,共置入Zero-P椎間融閤器31枚,融閤節段均為單節段。術後定期攝X線片檢查,採用日本骨科學會(JOA)評分,神經功能改善率(RIS)評價患者術前、術後頸脊髓神經功能。結果:31例患者均穫12箇月以上隨訪,平均14.70箇月,手術時間(72±10)min,術中齣血量(60±12)mL;1例患者術後24 h內齣現嚥部疼痛,經對癥治療,術後7 d內癥狀消失;術後3箇月X線片提示頸椎椎間隙骨性融閤,術前JOA評分(8.65±1.85)分,術後末次隨訪時為(16.09±0.91)分,差異有統計學意義(P<0.05);術後6箇月神經功能改善率為(89.60±9.45)%,與術後12箇月的(90.30±8.94)%比較,差異無統計學意義(P>0.05);術後椎間高度、生理弧度恢複滿意。結論:Zero-P椎間融閤器應用于頸前路減壓植骨融閤治療頸椎疾病的早期隨訪療效滿意。
목적:연구Zero-P추간융합기재경추전로감압추체간융합(ACDF)술후적조기림상료효。방법:선취경추질병환자31례,균행ACDF술,공치입Zero-P추간융합기31매,융합절단균위단절단。술후정기섭X선편검사,채용일본골과학회(JOA)평분,신경공능개선솔(RIS)평개환자술전、술후경척수신경공능。결과:31례환자균획12개월이상수방,평균14.70개월,수술시간(72±10)min,술중출혈량(60±12)mL;1례환자술후24 h내출현인부동통,경대증치료,술후7 d내증상소실;술후3개월X선편제시경추추간극골성융합,술전JOA평분(8.65±1.85)분,술후말차수방시위(16.09±0.91)분,차이유통계학의의(P<0.05);술후6개월신경공능개선솔위(89.60±9.45)%,여술후12개월적(90.30±8.94)%비교,차이무통계학의의(P>0.05);술후추간고도、생리호도회복만의。결론:Zero-P추간융합기응용우경전로감압식골융합치료경추질병적조기수방료효만의。
Objective:To research the early clinical efficacy of a Zero-Profile interbody fusion after anterior cervical decompression and fusion (ACDF)with internal fixation. Method:31 patients with cervical disorders were selected. All patients underwent ACDF with Zero-Profile Implant,31 cages were implanted,all were single segment. X-ray was taken conventionally after operation. The neurofunction follow-up was estimated by Japanese Orthopaedic Association and rate of the improved JOA score. Result:All of the patients were followed up above 12 months,arerage of 14.7 months,the operation was spent(72±10)min in patients,whose blood loss(60±12)mL. 1 patient felt pharyngeal pain in 24 hours after operation,this symptom cured in 7 days after corresponding therapy. All patients had the evidence of bridging trabecular bone with the fusion area after 3 months. Significant difference was evaluated on JOA score between preoperation(8.65±1.85)and final follow-up(16.09±0.91)(P<0.05),the RIS after 6 months post operation was(89.60±9.45)%and compared with after 12 months post operation(90.30±8.94)%,there was no difference(P>0.05). The interbody height and physiological curvature were recovered satisfactorily. Conclusion:The early clinical efficacy for Zero-Profile interbody fusion applied to anterior cervical decompression and fusion is satisfactory.